McFarland, T. R., Tandar, C. E., Agarwal, N., & Swami, U. (2021). Emergence of polyclonal BRCA2 reversions following PARP inhibitor treatment. Cancer Treatment and Research Communications, 29(100480-), . https://doi.org/10.1016/j.ctarc.2021.100480
Chicago-referens (17:e uppl.)McFarland, Taylor Ryan, Clara Elizabeth Tandar, Neeraj Agarwal, och Umang Swami. "Emergence of Polyclonal BRCA2 Reversions Following PARP Inhibitor Treatment." Cancer Treatment and Research Communications 29, no. 100480- (2021). https://doi.org/10.1016/j.ctarc.2021.100480.
MLA-referens (9:e uppl.)McFarland, Taylor Ryan, et al. "Emergence of Polyclonal BRCA2 Reversions Following PARP Inhibitor Treatment." Cancer Treatment and Research Communications, vol. 29, no. 100480-, 2021, https://doi.org/10.1016/j.ctarc.2021.100480.
